Cafepharma Today

January 31 2025 - AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Arthritis Drugs Must Strengthen Warning on Infections
Bloomberg
Thursday, September 4, 2008 - 2:47pm
tags:
Alexza Pharma Down the Road
Yahoo/Zacks.com
Thursday, September 4, 2008 - 11:15am
tags:
FDA staff note deaths in Pfizer bone drug study
Yahoo/Reuters
Thursday, September 4, 2008 - 11:14am
tags:
India Pharma Ranbaxy Fights FDA Charges
Businessweek
Thursday, September 4, 2008 - 11:13am
tags:
Vytorin may hold up long term despite recent woes
Reuters
Thursday, September 4, 2008 - 8:42am
tags:
ImClone asks FDA to approve Erbitux as primary treatment for head and neck cancers
Yahoo/AP
Thursday, September 4, 2008 - 8:26am
tags:
Neurocrine shares rise on elagolix trial results
Yahoo/AP
Thursday, September 4, 2008 - 8:25am
tags:
Forest Labs hits 7-year low on trial results
Yahoo/AP
Thursday, September 4, 2008 - 8:24am
tags:
Sciele Target the Buyout Price
Yahoo/Zacks.com
Thursday, September 4, 2008 - 8:22am
tags:
Cephalon ending Provigil promotion deal with Takeda
Bizjournals.com
Thursday, September 4, 2008 - 8:22am
tags:
FTC seeks more information on Teva's Barr takeover
Yahoo/AP
Thursday, September 4, 2008 - 8:21am
tags:
Daiichi Sankyo reports positive data for anticoagulant drug
Pharmaceutical Business Review
Thursday, September 4, 2008 - 8:20am
tags:
Akorn-Strides wins approval for two new drugs
Pharmaceutical Business Review
Thursday, September 4, 2008 - 8:18am
tags:
Merck KGaA, Ablynx sign up to $484 mln drug deal
Forbes
Thursday, September 4, 2008 - 8:17am
tags:
Top Statistician Says Vytorin Cancer Risk 'Not Ruled Out'
Forbes
Thursday, September 4, 2008 - 8:16am
tags:
Pfizer staking millions on Alzheimer's hunch
The Day, CT
Thursday, September 4, 2008 - 8:16am
tags:
Epix regains rights to MRA agent from Bayer
Marketwatch
Thursday, September 4, 2008 - 8:15am
tags:
A Win For Regeneron
Forbes
Thursday, September 4, 2008 - 8:12am
tags:
Flash: Vytorin Study Not A Conspiracy
Forbes
Thursday, September 4, 2008 - 8:11am
tags:
UCB Pharma to Rebrand as Specialty Company
PharmExec
Thursday, September 4, 2008 - 8:08am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information